UCSF Coronavirus Response: UCSF is partnering with public agencies to address the rapidly evolving outbreak and protect our communities. The UCSF COVID-19 Resources Website provides guidance and information for our patients, faculty, staff, trainees and learners.

Marina Roytman, MD

Title(s)Professor, Dean's Office
SchoolSchool of Medicine
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    Mount Sinai Hospital , New York, NY06/2003Internal Medicine
    OHSU, Portland, ORMD07/2000Medicine
    University of Hawaii, Honolulu, HIBA 05/1996Chemistry
    John Burns School of Medicine , Honolulu, HI07/2012Medical Education

    Collapse Overview 
    Collapse Overview
    Marina Roytman, M.D., F.A.C.P.
    Health Sciences Clinical Professor, UCSF

    Marina Roytman, M.D., FACP, is board certified in Internal Medicine and fellowship trained in Medical Education.

    Her interests include viral hepatitis, drug induced liver injury, autoimmune hepatitis, and medical education.

    She has won multiple awards for her presentations on hepatitis and drug induced liver injury. Dr. Roytman has also served as Hepatology Elective Supervisor and Hepatobiliary Journal and Research Club Moderator.

    She is a member of the American Association of Study of Liver Disease and an elected fellow of the American College of Physicians.

    Her hobbies include yoga, reading and creative writing. She is fluent in Russian.

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Boregowda U, Umapathy C, Halim N, Desai M, Nanjappa A, Arekapudi S, Theethira T, Wong H, Roytman M, Saligram S. Update on the management of gastrointestinal varices. World J Gastrointest Pharmacol Ther. 2019 Jan 21; 10(1):1-21. PMID: 30697445.
      View in: PubMed
    2. Boregowda U, Umapathy C, Nanjappa A, Wong H, Desai M, Roytman M, Theethira T, Saligram S. Endoscopic ultrasound guided gallbladder drainage - is it ready for prime time? World J Gastrointest Pharmacol Ther. 2018 Dec 05; 9(6):47-54. PMID: 30568842.
      View in: PubMed
    3. Roytman MM, Poerzgen P, Navarro V. Botanicals and Hepatotoxicity. Clin Pharmacol Ther. 2018 09; 104(3):458-469. PMID: 29920648.
      View in: PubMed
    4. Wong LL, Lacar L, Roytman M, Orloff SL. Urgent Liver Transplantation for Dietary Supplements: An Under-Recognized Problem. Transplant Proc. 2017 Mar; 49(2):322-325. PMID: 28219592.
      View in: PubMed
    5. Jaruvongvanich V, Spanuchart I, O-Charoen P, Kitamura C, Sumida L, Roytman M. An Unusual Cause of Altered Mental Status in Multiple Myeloma: An Extraosseous Manifestation. Hawaii J Med Public Health. 2016 04; 75(4):109-12. PMID: 27099806.
      View in: PubMed
    6. Roytman M, Ramkissoon R, Wu C, Hong L, Trujillo R, Huddleston L, Poerzgen P, Seto T, Wong L, Tsai N. Examining the clinical course of genotype 1 chronic hepatitis C patients treated with the cosmos regimen: including patients with advanced liver disease and East Asian ancestry. Hepatol Int. 2016 Jul; 10(4):616-23. PMID: 27026431.
      View in: PubMed
    7. Wu CJ, Roytman MM, Hong LK, Huddleston L, Trujillo R, Cheung A, Poerzgen P, Tsai NC. Real-world Experience with Sofosbuvir-based Regimens for Chronic Hepatitis C, Including Patients with Factors Previously Associated with Inferior Treatment Response. Hawaii J Med Public Health. 2015 Sep; 74(9 Suppl 2):3-7. PMID: 26793407.
      View in: PubMed
    8. Kim TI, Kagihara JE, Tsai NC, Roytman MM. Autoimmune Hepatitis in Hawai'i. Hawaii J Med Public Health. 2015 Aug; 74(8):270-4. PMID: 26279964.
      View in: PubMed
    9. Vo KP, Vutien P, Akiyama MJ, Vu VD, Ha NB, Piotrowski JI, Wantuck J, Roytman MM, Tsai N, Cheung R, Li J, Nguyen MH. Poor Sustained Virological Response in a Multicenter Real-Life Cohort of Chronic Hepatitis C Patients Treated with Pegylated Interferon and Ribavirin plus Telaprevir or Boceprevir. Dig Dis Sci. 2015 Apr; 60(4):1045-51. PMID: 25821099.
      View in: PubMed
    10. Roytman MM, Pörzgen P, Lee CL, Huddleston L, Kuo TT, Bryant-Greenwood P, Wong LL, Tsai N. Outbreak of severe hepatitis linked to weight-loss supplement OxyELITE Pro. Am J Gastroenterol. 2014 Aug; 109(8):1296-8. PMID: 25091255.
      View in: PubMed
    11. Marumoto A, Roytman MM, Tsai NC. Trial and error: investigational drug induced liver injury, a case series report. Hawaii J Med Public Health. 2013 Sep; 72(9 Suppl 4):30-3. PMID: 24052916.
      View in: PubMed
    12. Akiyama MJ, Piotrowski JI, Roytman MM, Chan SM, Hong LK, Huddleston L, Trujillo R, Tsai NC. New triple therapy for chronic hepatitis C: real life clinical experience in a community setting. Hawaii J Med Public Health. 2013 Sep; 72(9 Suppl 4):6-13. PMID: 24052911.
      View in: PubMed
    13. Roytman MM, Thomas SM, Jiang CS. Comparison of practice patterns of hospitalists and community physicians in the care of patients with congestive heart failure. J Hosp Med. 2008 Jan; 3(1):35-41. PMID: 18257099.
      View in: PubMed